Glenza 80 mg Capsule
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Glenza 80 mg Capsule

Glenza 80 mg Capsule

Glenza 80 mg Capsule contains enzalutamide 80 mg and is an oral anticancer medicine used for the treatment of prostate cancer. It belongs to the androgen receptor inhibitor class and is taken by mouth with or without food as prescribed by the doctor. Enzalutamide blocks androgen receptor signaling, helping slow the growth of prostate cancer cells.

BUY NOW

Category

Glenza may be used in different stages of advanced prostate cancer, including non-metastatic and metastatic castration-resistant disease and metastatic castration-sensitive disease. By inhibiting androgen receptor signaling, enzalutamide reduces the effect of male hormones that can stimulate prostate cancer cell growth. The recommended treatment schedule is determined by the treating oncologist based on the patient’s condition and overall treatment plan. Important treatment considerations include monitoring for fatigue, hypertension, falls, fractures, and seizure risk.

Technical Specification

Specification Details
Active Ingredient Enzalutamide
Strength 80 mg
Dosage Form Capsule
Pack Size 14 capsules
Route of Administration Oral
Manufacturer/Marketer Glenmark Pharmaceuticals Ltd

Product Also Known As

Glenza 80mg Capsule, Glenza 80 mg Soft Capsule, Enzalutamide 80mg Capsule, Enzalutamide 80 mg Capsule, Enzalutamide 80mg Softgel Capsule, Enzalutamide Prostate Cancer Capsule